# Case Health AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/case-health-ai

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.casehealth.ai/
- Latest round: Seed (Jan 15, 2026)
- Investors on record: 1

## About

Case Health AI, Inc., based in the US, specializes in AI-driven solutions that automate healthcare utilization management processes, focusing on streamlining prior authorization workflows for payers and providers.Founded in 2025, Case Health AI, Inc. operates out of San Francisco, US, providing AI technology to improve healthcare processes. The company was established by a group of entrepreneurs dedicated to innovation in healthcare. On January 15, 2026, the company completed a Seed funding round, securing investment to further its mission.Case Health AI primarily offers advanced AI-driven solutions designed to automate the prior authorization process within healthcare utilization management. Their flagship product utilizes proprietary AI models to handle critical tasks such as intake, document verification, and determination of approval or denial for prior authorization requests. Key components include the Clinical Abstraction Language Model (CALLM™) and the Evaluation Language Model (EVALLM™), which work in tandem to efficiently extract essential patient and provider information from prior auth documents and validate them against guidelines and payer rules. The end users of these solutions are primarily healthcare payers and providers looking to streamline operations and enhance compliance with regulations. The company's products are utilized in various geographical markets, focusing on the U.S. healthcare system where managing prior authorizations is crucial for operational efficiency.Case Health AI generates revenue through partnerships and direct sales of its AI automation solutions to healthcare organizations, particularly health plans. The transaction structure typically involves licensing agreements and possibly subscription models, allowing clients to integrate the AI systems into their existing utilization management workflows. The company emphasizes its ability to facilitate seamless processing with a significant reduction in administrative burdens and processing times. While specific pricing details for their products and services are not disclosed, the value proposition centers on substantial operational savings and improved accuracy in prior authorization decisions, which are critical for healthcare payers managing large volumes of requests. This approach positions Case Health AI as a vital partner for organizations aiming to enhance efficiency and compliance in their operations.In January 2026, Case Health AI plans to leverage its recent Seed funding to further develop and launch new AI-driven products aimed at enhancing the prior authorization process. The company is targeting expansion into additional markets, specifically focusing on the broader North American healthcare sector by the end of 2026. The funding will support product development and marketing efforts to establish a presence in these new regions.

## Funding rounds

- Seed, Jan 15, 2026 — Pioneer Fund

## Investors

- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed